Ocular Manifestations of Inflammatory Bowel Disease

Completed

• Conditions: Inflammatory Bowel Diseases; Ophthalmopathy
• Interventions: Other: reason for consultation

• Registration Number: NCT04771039
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-01
• Status Verified: 2020-12
• Primary Completion: 2020-12-01
• Study Completion: 2020-12-12
• Study First Submitted: 2021-01-04
• Study First Submitted QC: 2021-02-24
• Last Update Submitted: 2021-02-24
• Study First Posted: 2021-02-25
• Last Update Posted: 2021-02-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

• Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

Exclusion Criteria

• Minor patients
• patients without IBD
• patients for whom there is no ophthalmology consultation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients with chronic inflammatory bowel disease who consulted in ophthalmology	reason for consultation	-

Primary Outcome Measures

Name	Time	Method
frequency	baseline	frequency of ocular manifestations in inflammatory bowel disease

Secondary Outcome Measures

Name	Time	Method
Number	baseline	Number of uveitis, scleritis and episcleritis; prevalence calculation